Elevations of Cardiac Troponin‐I Quantified with the Erenna® cTnI Immunoassay are an Early Indicator of Heart Muscle Injury in Studies of Cardiotoxicity
30 March 2012

This application note describes the utility of the Erenna Immunoassay System and the Erenna cTnI Assay towards early assessment of cardiotoxicity in rats. Due to its unique high definition technology it is shown that elevated levels of cTnI in serum can be detected earlier with the Erenna Immunoassay System.

Popular tags in SelectScience

Buying guides

Write a Review

Join the Global SelectScience Community Today! It’s FREE!

Helping you make informed decisions about the latest lab products and technologies:

  • Be the first to learn about new technologies
  • 10,000+ trusted product reviews from your peers
  • Compare 500,000 products and manufacturers
  • Get exclusive buying tips from experts
  • Find solutions fast: 10,000+ Application Notes, Webinars and Videos

Connect with 250,000 scientists... All in one place!

Become a member today!